Age between 20 and 80 years
Patients undergoing percutaneous coronary intervention and need to take dual antiplatelet therapy continuously at least 12weeks
Modified Lanza Score grade 0-1 measured by upper gastrointestinal endoscopy
mild gastrointestinal symptom
Creatinen in blood = 3mg/dl
BUN = 50mg/dl
Birilubin = 3mg/dl
AST and ALT = 80U/L

NCT02175186_inc_T1
Person
Age
NCT02175186_inc_T2
Value
between 20 and 80 years
NCT02175186_inc_T3
Procedure
percutaneous coronary intervention
NCT02175186_inc_T4
Procedure
dual antiplatelet therapy
NCT02175186_inc_T5
Qualifier
continuously
NCT02175186_inc_T6
Temporal
at least 12weeks
NCT02175186_inc_T7
Measurement
Modified Lanza Score grade
NCT02175186_inc_T8
Value
0-1
NCT02175186_inc_T9
Procedure
upper gastrointestinal endoscopy
NCT02175186_inc_T10
Condition
gastrointestinal symptom
NCT02175186_inc_T11
Qualifier
mild
NCT02175186_inc_T12
Measurement
Creatinen
NCT02175186_inc_T13
Value
= 3mg/dl
NCT02175186_inc_T14
Measurement
BUN
NCT02175186_inc_T15
Value
= 50mg/dl
NCT02175186_inc_T16
Measurement
Birilubin
NCT02175186_inc_T17
Value
= 3mg/dl
NCT02175186_inc_T18
Measurement
AST
NCT02175186_inc_T19
Measurement
ALT
NCT02175186_inc_T20
Scope
AST and ALT
NCT02175186_inc_T21
Value
= 80U/L